Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Clinical Selection Criteria for a Second Cochlear Implant for Bimodal Listeners

Yoon, Yang-soo*; Shin, You-Ree; Fu, Qian-Jie*

doi: 10.1097/MAO.0b013e318259b8c0
Cochlear Implants

Objective To compare the speech perception benefit, provided by a contralateral hearing aid (HA) or a second cochlear implant (CI).

Study Design Repeated measures.

Patients A total of 25 adult subjects participated in the study, including 12 bilateral (10 female and 2 male patients) and 13 bimodal (6 female and 7 male subjects) users. All bilateral users were sequentially implanted. The bimodal users were separated into a poor group (n = 5, aided pure-tone average (PTA) of 55 dB HL or greater at audiometric frequencies of 1 kHz or lesser) and a good group (n = 8, aided PTA < 55 dB HL).

Main Outcome Measures Consonant, vowel, and sentence recognition was measured in quiet and noise at +5 dB and +10 dB signal-to-noise ratios (SNRs). Speech recognition performance was evaluated under three listening conditions: CI alone, HA alone, and CI+HA for bimodal users; first CI alone, second CI alone, and first CI + second CI for bilateral users when speech and noise were presented from the front.

Results There was no significant difference in the binaural benefit between the good bimodal and bilateral groups in vowel and sentence recognition. However, the binaural benefit is significantly better in the bilateral group than in the poor bimodal group for all 3 speech measures.

Conclusion These results suggest that the aided pure-tone average at audiometric frequencies of 1 kHz or lesser may serve as one of the clinical criteria for the recommendation of whether bimodal patients should consider a second cochlear implant to maximize their binaural listening ability.

*Division of Communication and Neuroscience, House Research Institute, Los Angeles, California, U.S.A.; and †Soree Ear Clinic The Future Center, Seoul, South Korea

Address correspondence and reprint requests to Yang-soo Yoon, Ph.D., House Research Institute, 2100 West Third Street, Los Angeles , CA 90057; E-mail:

Qian-Jie Fu has received research grants R01-DC004792 and R01-DC004993 from National Institutes of Health.

The other authors have no conflicts of interest to declare.

© 2012 Otology & Neurotology, Inc.